Back to Bills
SENATE-BILL 755119th Congress

SENATE-BILL 755: S.755 - Finn Sawyer Access to Cancer Testing Act

Introduced: February 26, 2025
Status: Referred to Committee
supported

AI-Powered Summary

Generated by AI Analysis

SENATE-BILL 755 aims to enhance access to cancer diagnostic and laboratory tests for individuals diagnosed with cancer by mandating coverage under Medicare, Medicaid, and CHIP. The bill addresses major themes of health care access and equity, particularly for vulnerable populations who depend on government assistance programs. Key provisions include a clear definition of covered cancer diagnostic tests, requirements for inclusion in medical assistance programs, and educational initiatives regarding genomic testing to promote informed consent. The implementation timeline allows for coverage to commence in 2027, providing states with necessary time to adjust their health care plans. Potential impacts include improved access to essential medical care for cancer patients, while also raising constitutional questions about federal mandates on health care coverage and the adequacy of such coverage in meeting constitutional standards.

Demographic Impact Analysis

AI Demographics Analysis

Summary

Overall Constitutional Implications

The bill's provisions to expand access to cancer testing under Medicare, Medicaid, and CHIP have significant constitutional implications, particularly in promoting health equity and addressing disparities among various demographic groups. By mandating coverage for these tests, the bill supports the notion of health care as a critical component of individual rights, even if not explicitly guaranteed by the Constitution.

Key Individual Rights Affected

  • Right to Health Care
  • Equal Protection under the Law

Constitutional Provisions

  • 14th Amendment - Equal Protection Clause
  • Tenth Amendment - States' Rights

Potential Constitutional Challenges Or Support

While the bill supports equal access to health care, it may face challenges regarding federal overreach and state sovereignty, particularly from states that may resist compliance with federal mandates. However, the potential benefits for marginalized groups could bolster arguments in favor of the bill's constitutionality.

Summary

SENATE-BILL 755 aims to improve access to cancer diagnostic tests, which could lead to better health outcomes for individuals across various demographic categories, including vulnerable populations such as seniors and low-income individuals. The bill's focus on equitable access aligns with constitutional principles, although careful implementation is necessary to ensure that it does not inadvertently exacerbate existing disparities.

Constitutional Analysis

supported

This bill appears to align with constitutional principles. The proposed legislation operates within the established framework of constitutional authority and does not appear to conflict with fundamental rights or the separation of powers.

Analysis generated using AI-powered review of constitutional principles and legal precedents.

Take Action

Text 50409

💡 How to use:

These links will start a conversation with ResistBot. When prompted, mention S. 755 to reference this bill.

Contact Your Representatives

Write to YOUR elected officials about this bill

Rate This Bill

Sign in to save a private rating for this bill and track your civic engagement over time.

Sign In Free

Timeline

February 26, 2025

Bill Introduced

Current

Referred to Committee

June 12, 2026

Last Updated

Ask the Constitutional AI About This Bill

Sign in free to chat with our constitutional analysis AI about this bill — get plain-English explanations, constitutional concerns, and demographic impact estimates personalized to you.

Sign In Free to Chat